Hypo Program app for iPhone and iPad
Developer: DDM Health
First release : 28 Jan 2019
App size: 43.83 Mb
The Hypo Program is the worlds first and only structured education program focused on improving hypoglycemia awareness.
The Hypo Program has personalised streams for:
* Patients with insulin-treated diabetes
* Parents of children with type 1 diabetes
* Teachers of children with type 1 diabetes
* Healthcare Professionals
GET STARTED
To get started, simply download the Hypo Program app and choose your stream.
EDUCATION
Immerse yourself in learning with over 20 hours of structured education personalised to your goals and program stream. CPD points are being confirmed for Healthcare Professionals and Teachers.
RESOURCES
Explore a personalised library of over 20 resources tailored to your goals and stream.
CHECK-INS
Answer the formative assessments at the end of each module to reflect upon, and reinforce your learning. Take part in regular check-ins to assess your hypoglycemia awareness and monitor hypoglycemic episodes.
Your data is helping reshape the understanding of hypoglycemia and its burden. After 6 months of completing the program:
* 88% of patients with diabetes report improved hypoglycemia awareness
* 88% of patients with diabetes confirm that they understand the rules/regulations around driving and hypoglycemia
* 2 in 3 patients with diabetes report experiencing fewer severe hypoglycemia episodes, saving the NHS over £3.1 million GBP in ambulance callouts alone
GET YOUR HYPO PROGRAM CERTIFICATE
Receive your exclusive Hypo Program Completion Certificate on finishing the Hypo Program. To get your Hypo Program Completion Certificate, complete all modules and score 100% to become a Verified Hypo Ninja.
SUPPORT
Access the Hypo Program from anywhere at any time on the web at HypoProgram.com or the native iOS mobile app. Send your feedback at any time through the app and receive a response within 48 business hours.
The Hypo Program is a Diabetes Digital Media (DDM) digital health solution made freely available through a partnership with Novo Nordisk.